Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Wakako Furuyama"'
Autor:
Tony W. Ng, Wakako Furuyama, Ariel S. Wirchnianski, Noemí A. Saavedra-Ávila, Christopher T. Johndrow, Kartik Chandran, William R. Jacobs, Andrea Marzi, Steven A. Porcelli
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Previous studies have demonstrated the efficacy and feasibility of an anti-viral vaccine strategy that takes advantage of pre-existing CD4+ helper T (Th) cells induced by Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccination. This strategy u
Externí odkaz:
https://doaj.org/article/f8873c18c52a478ba7ece8617e9ee5b6
Autor:
Daisuke Sasaki, Tatsuya Arai, Yue Yang, Masahiro Kuramochi, Wakako Furuyama, Asuka Nanbo, Hiroshi Sekiguchi, Nobuhiro Morone, Kazuhiro Mio, Yuji C. Sasaki
Publikováno v:
Biochemistry and Biophysics Reports, Vol 38, Iss , Pp 101712- (2024)
Single-molecule intramolecular dynamics were successfully measured for three variants of SARS-CoV-2 spike protein, alpha: B.1.1.7, delta: B.1.617, and omicron: B.1.1.529, with a time resolution of 100 μs using X-rays. The results were then compared
Externí odkaz:
https://doaj.org/article/e11640f8ec6b41749adcc6e2be830094
Autor:
Shoichi Ashida, Shohei Kojima, Takashi Okura, Fumihiro Kato, Wakako Furuyama, Shuzo Urata, Yusuke Matsumoto
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 5 (2024)
ABSTRACTParamyxo- and filovirus genomes are equipped with bipartite promoters at their 3' ends to initiate RNA synthesis. The two elements, the primary promoter element 1 (PE1) and the secondary promoter element 2 (PE2), are separated by a spacer reg
Externí odkaz:
https://doaj.org/article/e85cb5e364034fd5b2791d9b47613bce
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
Ebola virus (EBOV) causes severe EBOV disease (EVD) in humans and non-human primates. Currently, limited countermeasures are available, and the virus must be studied in biosafety level-4 (BSL-4) laboratories. EBOV glycoprotein (GP) is a single transm
Externí odkaz:
https://doaj.org/article/b8c24b1e5f8f45d5b9e8b1576cf869b8
Autor:
Andrew Young, Ariel Isaacs, Connor A. P. Scott, Naphak Modhiran, Christopher L. D. McMillan, Stacey T. M. Cheung, Jennifer Barr, Glenn Marsh, Nazia Thakur, Dalan Bailey, Kenneth S. M. Li, Hayes K. H. Luk, Kin-Hang Kok, Susanna K. P. Lau, Patrick C. Y. Woo, Wakako Furuyama, Andrea Marzi, Paul R. Young, Keith J. Chappell, Daniel Watterson
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The COVID-19 pandemic response has shown how vaccine platform technologies can be used to rapidly and effectively counteract a novel emerging infectious disease. The speed of development for mRNA and vector-based vaccines outpaced those of subunit va
Externí odkaz:
https://doaj.org/article/8e789c5618974f6bb15905f04f170ac6
Autor:
Kosuke Okuya, Takanari Hattori, Takeshi Saito, Yoshihiro Takadate, Michihito Sasaki, Wakako Furuyama, Andrea Marzi, Yoichi Ohiro, Satoshi Konno, Takeshi Hattori, Ayato Takada
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 2 (2022)
ABSTRACT Antibody-dependent enhancement (ADE) of infection is generally known for many viruses. A potential risk of ADE in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has also been discussed since the beginning of the coron
Externí odkaz:
https://doaj.org/article/6254e3c4b58a4bbf8d3323c4c98c075c
Autor:
Wakako Furuyama, Kyle Shifflett, Amanda N. Pinski, Amanda J. Griffin, Friederike Feldmann, Atsushi Okumura, Tylisha Gourdine, Allen Jankeel, Jamie Lovaglio, Patrick W. Hanley, Tina Thomas, Chad S. Clancy, Ilhem Messaoudi, Kyle L. O’Donnell, Andrea Marzi
Publikováno v:
mBio, Vol 13, Iss 1 (2022)
ABSTRACT The ongoing pandemic of coronavirus (CoV) disease 2019 (COVID-19) continues to exert a significant burden on health care systems worldwide. With limited treatments available, vaccination remains an effective strategy to counter transmission
Externí odkaz:
https://doaj.org/article/b1453d6466b74f36931bb1ccc3680e0a
Autor:
Kyle L. O’Donnell, Chad S. Clancy, Amanda J. Griffin, Kyle Shifflett, Tylisha Gourdine, Tina Thomas, Carrie M. Long, Wakako Furuyama, Andrea Marzi
Publikováno v:
Frontiers in Immunology, Vol 12 (2022)
The ongoing COVID-19 pandemic has resulted in global effects on human health, economic stability, and social norms. The emergence of viral variants raises concerns about the efficacy of existing vaccines and highlights the continued need for the deve
Externí odkaz:
https://doaj.org/article/4723af40df4f4d9e985889272c0e5386
Autor:
Chih-Yun Lai, Albert To, Teri Ann S. Wong, Michael M. Lieberman, David E. Clements, James T. Senda, Aquena H. Ball, Laurent Pessaint, Hanne Andersen, Wakako Furuyama, Andrea Marzi, Oreola Donini, Axel T. Lehrer
Publikováno v:
Vaccine: X, Vol 9, Iss , Pp 100126- (2021)
The speed at which several COVID-19 vaccines went from conception to receiving FDA and EMA approval for emergency use is an achievement unrivaled in the history of vaccine development. Mass vaccination efforts using the highly effective vaccines are
Externí odkaz:
https://doaj.org/article/4899da1012804294873b875b8874ede5
Publikováno v:
PLoS Pathogens, Vol 17, Iss 9, p e1009937 (2021)
Ebola virus (EBOV) expresses three different glycoproteins (GPs) from its GP gene. The primary product, soluble GP (sGP), is secreted in abundance during infection. EBOV sGP has been discussed as a potential pathogenicity factor, however, little is k
Externí odkaz:
https://doaj.org/article/cc83fff300b74ca9a612f028f74f0da2